Abstract
In vitro platelet proaggregating effect of unfractionated heparin (H) and OP/LMWH were studied with human platelets. OP/LMWH produced a significant less potentiation of ADP and PAF induced aggregation and slightly counteracted the antiaggregating effect of PGI2, in comparison with H.
The proaggregating effect of both heparins was neutralized by equal contemporaneous amount of protamine sulfate.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
E.W. Salzman, R.D. Rosenberg, M.N. Smith, J.N. Lindon andL. Favreau,Effect of heparin and heparin fractions on platelet aggregation, J. Clin. Invest.65, 64–73 (1980).
R. Mastacchi, L. Stanzani, M. Barbanti, L. Montecchi andP. Bianchini,Interaction of heparin and heparin fractions with human platelets, Thromb. Res.28, 275–280 (1982).
P.J. Powers, J.G. Kelton andC.J. Carter,Studies on the frequency of heparin-associated thrombocytopenia, Thromb. Res.33, 439–443 (1984).
E. Holmer, U. Lindhal, G. Bäckström, L. Thunberg, H. Sandberg, G. Söderström andL.O. Andersson,Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombin, Thromb. Res.18, 861–869 (1980).
F. Fabris, F. Fussi, A. Casonato, L. Visentin, M. Randi, M.R. Smith andA. Girolami,Normal and low molecular weight heparins: interaction with human platelets, Eur. J. Clin. Invest.13, 135–139 (1983).
F.W. Dunn, C. Soria, A. Thomaidis, E. Dupuy, S. Bellucci andG. Tobelem,Interactions of platelets with standard heparin and low molecular weight fractions, Nouv. Rev. Fr. Hematol.26, 249–253 (1984).
F. Foque andB.B. Vargaftig,Triggering by PAF-acether and adrenaline of cyclooxigenase-independent platelet aggregation, Brit. J. Pharmacol.83, 625–633 (1984).
D.E. McIntyre, R.I. Handin, R. Rosenberg andE.W. Salzman,Heparin opposes prostanoid and non prostanoid platelet inhibitors by direct enhancement of aggregation, Thromb. Res.22, 167–175 (1981).
V. Bertele, M.C. Roncaglioni, M.B. Donati andG. De Gaetano,Heparin counteracts the antiaggregating effect of prostacyclin by potentiating platelet aggregation, Thromb. Haemost.49, 81–83 (1983).
G. Andriuoli, R. Mastacchi, M Barbanti andM. Sarret,Antithrombotic activity of a low molecular weight heparin (LMWH) as compared with conventional heparin (H) in venous thrombosis models in rat, VIIIth International Congress on thrombosis, Istanbul, June 4–7 (1984).
G. Andriuoli, R. Mastacchi, M. Barbanti andM. Sarret,Comparison of the antithrombotic and haemorrhagic effects of heparin and a new low molecular weight heparin in rats, Haemostasis, in press (1985).
P. Bianchini, B. Osima, B. Parma, C.P. Dietrich andH.K. Takahashi,Structural studies and in vivoand in vitropharmacological activities of heparin fractions and fragments prepared by chemical and enzymic depolimerization, Thromb. Res., in press (1985).
G.P. Corbelli, L. Stanzani, R. Mastacchi, M. Barbanti andL. Montecchi Effect of SAS 650 (Furofenac) on malondialdehyde production by platelets, Agents and Actions14, 735–737 (1984).
J.M. Walenga, J. Fareed andD.A. Hoppensteadt, In vitroanticoagulant and amidolytic methods for evaluating the activity of heparin and a low molecular weight derivative (PK 10169), Seminars in thrombosis and haemostasis11, 17–25 (1985).
A.R. Hubbard andC.A. Jennings,Neutralization of heparin sulphate and low molecular weight heparin by protamine, Thromb. Haemost.53, 86–89 (1985).
M. Ruggiero, S. Fedi, P. Bianchini, S. Vannucchi andV. Chiarugi,Molecular events involved in the proaggregating effect of heparin on human platelets, Biochim. Biophys. Acta802, 372–377 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mastacchi, R., Barbanti, M., Bianchini, P. et al. Interaction of a new low molecular weight heparin (OP/LMWH) with human platelets. Agents and Actions 17, 512–514 (1986). https://doi.org/10.1007/BF01965523
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01965523